Seton Hall Law School Asia-Pacific Healthcare Compliance Certificate Program 2026

In the Asia-Pacific region and beyond, the pharmaceutical, biotech, and medical device industries face an increasingly complex regulatory and enforcement landscape.

Our Hong Kong dispute resolution partner B. Chen Zhu, along with Nicholas Seng, Legal Director, Investigations & Litigation, APAC, Johnson & Johnson (Singapore), will be speaking on the topic of “Global Anti-Corruption Enforcement” during the Seton Hall Law School’s Asia-Pacific Healthcare Compliance Certificate Program.

The discussion will cover key topics, including:

• Overview of the FCPA and anticorruption laws in major APAC markets
• Impact of shift in FCPA enforcement priorities on life sciences companies
• Recent anti-corruption trends in the healthcare sector in China, Japan, South Korea and Southeast Asia.

Organized by Seton Hall Law School, the four-day Healthcare Compliance Certificate Program aims to provide essential legal knowledge and an ethical foundation for healthcare compliance professionals, including in-house and outside legal counsel, regulatory specialists, medical affairs officers, ethics and integrity officers, auditors, and consultants to the pharmaceutical, biotech, and medical device industries.

Learn more about this event and our FCPA + Global Anti-Corruption practice.